Beechbrook Capital has invested €7.5 million in Bio-Medical Research Limited to support its expansion in the fitness and wellness technology sector in Ireland.
Target Company Overview
Bio-Medical Research Limited (BMR) is a prominent player in the electrical muscle stimulation technology sector, primarily serving the fitness and wellness industries. Founded in 1969 and headquartered in Galway, Ireland, BMR has secured its position as a market leader with a notable product range, including the widely recognized Slendertone and Flex Belt. With a strong presence in European, Asian, and North American markets, BMR is well-positioned for further growth and innovation.
Under the leadership of Chairman Bernard Collins and CEO Brian Sheehan, BMR aims to expand its market-leading product portfolio. The recent investment of €7.5 million from Beechbrook Capital will provide the necessary financial backing to enhance their product offerings and accelerate their growth initiatives.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Ireland
The fitness and wellness sector in Ireland has seen robust growth, driven by increasing consumer awareness and demand for health-focused solutions. The rise of fitness technology has further prop
Similar Deals
Claret Capital Partners → Deciphex
2025
Gilde Healthcare, Viking Global Investors → Mainstay Medical Holdings plc
2024
BGF → Avoca Clinic
2023
Unmind → Frankie Health
2023
BDO Development Capital Fund → Lifes2good Group
2015
BDO Development Capital Fund → Perigord
Beechbrook Capital
invested in
Bio-Medical Research Limited
in 2019
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $8M